News from Generex Biotechnology Corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Oct 15, 2015, 09:30 ET Generex Announces Memorandum of Understanding in respect of a Phase II Clinical Trial for the Antigen Express Prostate Cancer Vaccine

Antigen Express to work with CompanDX Ltd. in the UK Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) today announced that...


Oct 13, 2015, 09:30 ET Generex Announces Agreement to Acquire Equity Interest in MediTemp Ltd.

 Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) today announced that it has entered into a non-binding Letter of Intent...


Oct 06, 2015, 09:30 ET Generex Announces Agreement to Acquire Equity Interest in Alfa Rhythm Ltd.

A unique opportunity for GNBT to expand the scope of its business  Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT)...


Oct 01, 2015, 09:30 ET Generex Announces Issuance of Buccal Cannabis White Paper

Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) today announced the issuance of a white paper on the use of cannabis for...


Sep 30, 2015, 09:30 ET Generex Announces Agreement to Acquire Equity Interest in Hema Diagnostic Systems

Generex seeks to augment the Antigen Express work In infectious diseases with the HDS detection technologies Generex Biotechnology Corporation...


Sep 08, 2015, 09:30 ET Generex Announces Commencement of Buccal Leuprolide R&D Work

Collaboration with NHTherapeutics has begun  Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) today announced that...


Sep 02, 2015, 09:30 ET Generex Announces Formalization of Buccal Cannabis Co-Development Plan

Contract signed with CannScience Innovations Inc.  Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) today announced that...


Feb 17, 2015, 09:30 ET Generex Provides Update on Antigen Express Phase II AE37 Breast Cancer Vaccine Trial

 Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) today announced that results of the last pre-specified analysis of data from...


Dec 17, 2014, 09:00 ET Generex Announces Participation in MedCannAccess® - CannScience Partnership on Non-Smoked Forms of Marijuana

Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced its participation in a MedCannAccess (www.MedCannAccess.com)...


Nov 18, 2014, 09:30 ET Generex Announces Collaboration on Medicinal Cannabis

 Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today announced that it has entered into a non-binding Letter of Intent...


Nov 11, 2014, 09:30 ET Generex Announces Presentation at the Society for Immunotherapy of Cancer Demonstrating that Induction of Antibody Response in Patients Receiving the AE37 Breast Cancer Vaccine Correlates with Reduced Relapse

Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) today announced a presentation showing that induction of an antibody response to...


Oct 27, 2014, 09:30 ET Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons

Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) today announced two presentations demonstrating that the extent of the...


Oct 23, 2014, 09:30 ET Generex / Antigen Express to Participate in 2014 BIO-Europe® Annual International Partnering Conference

 Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today announced that the Company's wholly-owned subsidiary, Antigen Express,...


Oct 21, 2014, 09:30 ET Generex Announces Publication of Ebola Vaccine White Paper by Antigen Express

 Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced that its wholly owned subsidiary, Antigen Express, Inc....


Oct 07, 2014, 09:30 ET Generex Clarifies Utility of Antigen Express Technology for Potential Ebola Vaccine

 Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today responded to a recent article posted to the Seeking Alpha website...


Sep 30, 2014, 09:30 ET Generex Announces Engagement of Dr. Lakshmi P. Kotra for Buccal Insulin Enhancement Project

Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced that it has engaged Dr. Lakshmi P. Kotra, B. Pharm.(Hons), Ph.D.,...


Sep 22, 2014, 09:30 ET Generex Collaborates with University Health Network for Buccal Insulin Project

Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced that it has entered into a collaboration with University Health...


Sep 03, 2014, 09:15 ET Generex / Antigen Express to Participate in BioPharm America™ 2014

 Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced that the Company's wholly-owned subsidiary, Antigen Express,...


Aug 06, 2014, 09:30 ET Generex Announces Publication of AE37 Prostate Cancer Vaccine Study

 Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced publication of a follow-up study from a Phase I clinical...


Jun 10, 2014, 09:30 ET Generex / Antigen Express to Participate in 2014 BIO International Convention

Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced that the Company's wholly-owned subsidiary, Antigen Express, Inc....


May 20, 2014, 09:30 ET Generex Announces Presentation of Primary Efficacy Data & Immunological Response from the Phase II Study of AE37 Cancer Vaccine at ASCO

Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced two upcoming presentations demonstrating that certain patients...


Mar 27, 2014, 09:30 ET Generex Announces $2,075,000 Capital Investment

 Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today announced that it entered into a securities purchase agreement with...


Mar 26, 2014, 09:30 ET Generex/Antigen Express Announces Participation on Panel at Upcoming Cancer Immunotherapeutics Symposium

Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced that Dr. Eric von Hofe, Ph.D., the President of its wholly-owned...


Feb 12, 2014, 09:30 ET Generex Provides Update on Antigen Express Phase II AE37 Breast Cancer Vaccine Trial

Generex Biotechnology Corporation (www.generex.com) (GNBT) today announced that recent results from a Phase II study of a novel cancer vaccine...


Jan 13, 2014, 09:30 ET Generex Announces Completion of Enrollment of Antigen Express Phase II AE37 Breast Cancer Vaccine Trial

 Generex Biotechnology Corporation (www.generex.com) (OTCBB:GNBT) today announced completion of enrollment of the Antigen Express, Inc....